quidel corp (QDEL:NASDAQ GS)
quidel corp (QDEL) Snapshot
|
Open
$22.04
|
Previous Close
$22.10
|
|
|
Day High
$22.89
|
Day Low
$22.04
|
|
|
52 Week High
03/6/13 - $24.95
|
52 Week Low
08/2/12 - $14.92
|
|
|
Market Cap
763.0M
|
Average Volume 10 Days
128.6K
|
|
|
EPS TTM
$0.51
|
Shares Outstanding
33.7M
|
|
|
EX-Date
--
|
P/E TM
44.4x
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
quidel corp (QDEL) Related Businessweek News
No Related Businessweek News Foundquidel corp (QDEL) Details
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women’s health, and gastrointestinal diseases. The company’s products for infectious diseases include QuickVue influenza test to detect viral antigens of influenza type A and B; QuickVue Strep A tests to detect Group A Streptococcal antigen from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture; QuickVue RSV test, a rapid immunoassay for respiratory syncitial virus; and cell culture and DFA detection solutions to detect seven viral respiratory pathogens. It also offers cell-based products in various formats, including tubes, shell vials, and multi-well plates to culture and test for human viruses; ELVIS HSV system for the isolation and detection of herpes simplex virus (HSV) types 1 and 2; and a multiplex cell culture solution to isolate HSV, varicella zoster virus, and cytomegalovirus, as well as provides various analyzers and molecular assays. The company’s products for women’s health consist of QuickVue and RapidVue pregnancy tests to detect human chorionic gonoadotropin in serum or urine for the early detection of pregnancy; Thyretain for the diagnosis of graves, an autoimmune disease; QuickVue Chlamydia test to detect chlamydia trachomatis from endocervical swab and cytology brush specimens; and clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, including metabolic bone markers to monitor the effectiveness of therapy in pharmaceutical and related research. In addition, it provides a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; and Helicobacter pylori tests, as well as develops diagnostic and research products in the fields of oncology, bone health, and autoimmune diseases. The company was founded in 1979 and is headquartered in San Diego, California.
quidel corp (QDEL) Top Compensated Officers
quidel corp (QDEL) Key Developments
Quidel Corporation provided tax rate guidance for the year 2013. For the year, the company estimated effective tax rate to be in the range of 30% to 32%.
Quidel Corp. announced unaudited consolidated earnings results for the first quarter ended March 31, 2013. Total revenues for the first quarter of 2013 were $62.0 million as compared to $38.0 million in the first quarter of 2012. The increase in Revenue was driven by greater sales of infectious disease products due to a stronger influenza and respiratory disease season, as compared to the first quarter of 2012. Net income for the first quarter of 2013 was $12.4 million, or $0.36 per diluted share, compared to $0.05 million, or $0.00 per diluted share, for the first quarter of 2012. On a non-GAAP basis, excluding amortization of intangibles and stock compensation expense, net income for the first quarter of 2013 was $17.0 million, or $0.49 per diluted share, compared to $3.7 million, or $0.11 per diluted share, for the same period in 2012. Operating income was $17,189,000 against $470,000 a year ago. Income before taxes was $16,991,000 against $81,000 a year ago.
Quidel Corp. announced that they will report Q1, 2013 results at 5:00 PM, Eastern Standard Time on Apr 23, 2013
| Recently Viewed | |||
| QDEL:US | $22.62 USD | +0.52 | |
| Company | Last | Change |
| Affymetrix Inc | $3.67 USD | -0.01 |
| Haemonetics Corp | $41.08 USD | -0.20 |
| Ion Beam Applications | €5.54 EUR | 0.00 |
| Meridian Bioscience Inc | $21.89 USD | +0.23 |
| Response Biomedical Corp | C$3.48 CAD | +0.38 |
| View Industry Companies | ||
Industry Analysis
QDEL
Industry Average
| Valuation | QDEL | Industry Range |
| Price/Earnings | 44.6x |
|
| Price/Sales | 4.2x |
|
| Price/Book | 3.5x |
|
| Price/Cash Flow | 31.4x |
|
| TEV/Sales | 4.0x |
|
Post a JobJobs
- San Diego, CA | QuidelPosted: May 14
- San Diego, CA | QuidelPosted: May 25
- Athens, OH | QuidelPosted: May 22
- Athens, OH | QuidelPosted: May 19
Sponsored Financial Commentaries
Sponsored Links
To contact QUIDEL CORP, please visit www.quidel.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








